Bluejay Diagnostics Inc (BJDX) has a current Price-to-Book (P/B) ratio of 0.29. Compared to its 3-year average P/B ratio of 0.47, the current P/B ratio is approximately -38.68% higher. Relative to its 5-year average P/B ratio of -0.35, the current P/B ratio is about -182.89% higher. Bluejay Diagnostics Inc (BJDX) has a Forward Free Cash Flow (FCF) yield of approximately -509.55%. Compared to its 3-year average FCF yield of -368.29%, the current FCF yield is approximately 38.35% lower. Relative to its 5-year average FCF yield of -263.80%, the current FCF yield is about 93.16% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for BJDX competitors is 0.26, providing a benchmark for relative valuation. Bluejay Diagnostics Inc Corp (BJDX.O) exhibits a P/S ratio of 0.73, which is 174.11% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of BJDX increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of BJDX in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is BJDX currently overvalued or undervalued?

What is Bluejay Diagnostics Inc (BJDX) fair value?

BJDX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Bluejay Diagnostics Inc (BJDX) is between 1.78 to 4.54 according to relative valuation method.

How does BJDX's valuation metrics compare to the industry average?

The average P/S ratio for BJDX's competitors is 0.26, providing a benchmark for relative valuation. Bluejay Diagnostics Inc Corp (BJDX) exhibits a P/S ratio of 0.73, which is 174.11% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Bluejay Diagnostics Inc (BJDX) as of Mar 02 2026?

As of Mar 02 2026, Bluejay Diagnostics Inc (BJDX) has a P/B ratio of 0.29. This indicates that the market values BJDX at 0.29 times its book value.

What is the current FCF Yield for Bluejay Diagnostics Inc (BJDX) as of Mar 02 2026?

As of Mar 02 2026, Bluejay Diagnostics Inc (BJDX) has a FCF Yield of -509.55%. This means that for every dollar of Bluejay Diagnostics Inc's market capitalization, the company generates -509.55 cents in free cash flow.

What is the current Forward P/E ratio for Bluejay Diagnostics Inc (BJDX) as of Mar 02 2026?

As of Mar 02 2026, Bluejay Diagnostics Inc (BJDX) has a Forward P/E ratio of -0.00. This means the market is willing to pay $-0.00 for every dollar of Bluejay Diagnostics Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Bluejay Diagnostics Inc (BJDX) as of Mar 02 2026?

As of Mar 02 2026, Bluejay Diagnostics Inc (BJDX) has a Forward P/S ratio of 0.73. This means the market is valuing BJDX at $0.73 for every dollar of expected revenue over the next 12 months.

BJDX Valuation